Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Human Genome Variation is Scopus-indexed (Q4, CiteScore 2.3), WoS ESCI, DOAJ. Published by Springer Nature.
Checked against the index lists dated .
ISSN 2054-345XVerify ISSN ↗
Publisher: Springer Nature
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry | 347 / 448 | 22nd | Q4 |
| Genetics | 280 / 357 | 21st | Q4 |
| Molecular Biology | 339 / 414 | 18th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q4, CiteScore 2.3.
Human Genome Variation is Q4 in Biochemistry (rank 347 of 448), Q4 in Genetics (rank 280 of 357) and Q4 in Molecular Biology (rank 339 of 414), by CiteScore 2025.
Human Genome Variation is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q4 at the 22nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.535, quartile Q3, with an H-index of 28.
The publisher lists an article processing charge of about US$3,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Human Genome Variation is published by Springer Nature. Its ISSN is 2054-345X.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Human Genome Variation has an h-index of 33 and a 2-year mean of 1.81 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q4. On 2-year citations it ranks #285 of 442 Scopus journals in Biochemistry.
Human Genome Variation published 29 papers in 2025; its busiest recent year was 2019 with 56. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from Japan (76.5%), Iran (3%) and India (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.